To further confirm the relationship of OCT4 and p53 expression profiling with HPV16 background in cervical cancer, the Aptima HPV assay was used for the selection of HPV-negative tissues, while the Aptima HPV16 18/45 genotype assay was performed to obtain the HPV16-positive tissues for the subsequent experiments. The gene discussed is TP53; the disease is cervical carcinoma.